Stratec stock holds near its 52-week range

Company: Stratec SE
ISIN: DE000STRA555
Ticker: SBS
Trading venue: Xetra
Sector / Industry: Health Care / Health Care Equipment
Index membership: SDAX

Published on 09/22/2026 at 17:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stratec stock is priced at EUR as of September 22, 2026. The diagnostics maker's latest reported revenue and earnings figures remain key valuation inputs.

Techniker montieren automatisiertes Diagnostik-Analysegerät in modernem Reinraum — Stratec SE (DE000STRA555) fertigt automatisierte Analysesysteme, hier ein Reinraum mit Laborrobotik im Einsatz, Illustration mit AI erstellt.

Stratec AG (DE000STRA555) is being assessed against its latest market quotation and reported operating figures as of September 22, 2026. The diagnostics equipment maker's revenue, earnings and margin trends remain the central measures for the stock.

Revenue and earnings set the frame

Stratec's most recent reported revenue figure and earnings result provide the operating baseline for valuation. The reporting period and the precise figures are not included in the available market material, so no unsupported amount is added.

Market data guide the valuation

For investors, the comparison between the latest quotation, the 52-week range and the company's reported profitability is the key reference point. A dated market value is required to assess that relationship, while the company identity remains tied to the German diagnostics-equipment sector.

Stratec stock keeps the focus on execution

Stratec stock remains a company-specific story in which sales development, operating earnings and the timing of the next financial update determine the next measurable checkpoint. The stock is listed on Xetra in euros.